Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)
Clinical trial NCT05175950 · UNKNOWN
Trial details
- NCT number
- NCT05175950
- Sponsor
- Korea University Guro Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2023-08-01
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.